Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 406 AL 420

Cannabidiol and Alzheimer Disease: A Comprehensive Review and In Silico Insights Into Molecular Interactions

Mello-Hortega JV, de Oliveira CS, de Araujo VS, Furtado-Alle L, Tureck LV, Souza RLR.

Eur J Neurosci. 2025 Aug;62(4):e70229. doi: 10.1111/ejn.70229.

Insights into CYP450 polymorphisms and their impact on drug metabolism in Alzheimer's disease therapy

Zheng J, Liu G, Wang Q, Liang Y.

Drug Metab Rev. 2025 Nov;57(4):523-534. doi: 10.1080/03602532.2025.2552786. Epub 2025 Sep 3.

Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Roles in Normal Physiology and Disease

Jadhav D, Knapinska AM, Wang H, Fields GB.

Biomolecules. 2025 Aug 3;15(8):1114. doi: 10.3390/biom15081114.

Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future research

Singhaarachchi PH, Antal P, Calon F, Culmsee C, Delpech JC, Feldotto M, Geertsema J, Hoeksema EE, Korosi A, Layé S, McQualter J, de Rooij SR, Rummel C, Slayo M, Sominsky L, Spencer SJ.

Prog Neurobiol. 2025 Sep;252:102821. doi: 10.1016/j.pneurobio.2025.102821. Epub 2025 Aug 29.

[Aβ Receptor PirB and its regulation by LOTUS]

Kawaguchi Y, Takei K.

Nihon Yakurigaku Zasshi. 2025;160(5):318-323. doi: 10.1254/fpj.25018.

Hydrogen sulfide in the brain as a silent neuroprotector in Alzheimer's disease

Layal H, Rajbongshi J, Kumar R, Pandey S, Mishra R, Yadav PK.

Neuroscience. 2025 Oct 15;585:181-197. doi: 10.1016/j.neuroscience.2025.08.057. Epub 2025 Sep 2.

[Anti-amyloid antibodies for the treatment of early-stage Alzheimer's disease]

Frederiksen KS, Gramkow MH, Hasselbalch SG, Law I, Waldemar G.

Ugeskr Laeger. 2025 Aug 25;187(35):V03250217. doi: 10.61409/V03250217.

Exploring LRP-1 in the liver-brain axis: implications for Alzheimer's disease

Sharma VK.

Mol Biol Rep. 2025 Sep 8;52(1):873. doi: 10.1007/s11033-025-10980-8.

Acetylcholinesterase as a Multifunctional Target in Amyloid-Driven Neurodegeneration: From Dual-Site Inhibitors to Anti-Agregation Strategies

Grabowska W, Bijak M, Szelenberger R, Gorniak L, Podogrocki M, Harmata P, Cichon N.

Int J Mol Sci. 2025 Sep 7;26(17):8726. doi: 10.3390/ijms26178726.

Interplay of Glut1 alteration and Alzheimer's disease: A narrative review on glucose transport and energy metabolism

Fakorede S, Sodiq TA, Ajagbe AO, Adeleke AJ, Edafetanure-Ibeh OM, Awobona TA, Aborode AT.

J Alzheimers Dis. 2025 Nov;108(2):470-486. doi: 10.1177/13872877251377793. Epub 2025 Sep 12.

Research Progress in Application of Sensory Stimulation Therapy in Patients With Alzheimer's Disease

Liu P, Zhang Y, Meng QH.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2025 Aug;47(4):621-627. doi: 10.3881/j.issn.1000-503X.16375.

Medicinal chemistry-based novel herapeutics for Tauopathies in Alzheimer's disease

Chinnathambi S, Malik S, Chandrashekar M, Kumurappan M.

Adv Protein Chem Struct Biol. 2025;147:151-175. doi: 10.1016/bs.apcsb.2024.09.001. Epub 2024 Sep 20.

Tau protein structure and dynamics

Chinnathambi S, Velmurugan G, Chandrashekar M.

Adv Protein Chem Struct Biol. 2025;147:241-258. doi: 10.1016/bs.apcsb.2024.09.002. Epub 2024 Sep 20.

Mapping the pathogenic nexus: Gene overlap and protein interaction networks in Alzheimer's and breast cancer as a precursor to protein structure prediction and analysis

Chowdhury MR, Deepa VS, Raja VK.

Adv Protein Chem Struct Biol. 2025;147:275-331. doi: 10.1016/bs.apcsb.2024.11.007. Epub 2025 Apr 4.

Role and relation of cell death in Alzheimer's disease

Hoang DA, Le DA, Do TMH, Than VT.

Prog Mol Biol Transl Sci. 2025;217:263-303. doi: 10.1016/bs.pmbts.2025.06.024. Epub 2025 Jul 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias